Novel oral anticoagulants are similar to conventional treatment for venous thromboembolism
Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: Direct and adjusted indirect meta-analysis of randomised controlled trialsBMJ. 2012 Nov 13;345:e7498. doi: 10.1136/bmj.e7498
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
This meta-analysis and systematic review included 9 studies comparing novel oral anticoagulants (with or without initial treatment with heparin) to vitamin K antagonists (always with inital treatment with heparin) in patients with acute venous thromboembolism. From the 9 studies, 16 701 patients were assessed with regards to the efficacy of the drugs and 16 611 were evaluated on safety. Results in...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE